The treatment of pyoderma gangrenosum using etanercept.
Roy
David B
DB
Conte
Eugene T
ET
Cohen
David J
DJ
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000453:epidemiology; D015897:Comorbidity; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use*; D008178:Lupus Erythematosus, Cutaneous; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D012008:Recurrence
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept